YOUNGMAY Secures Strategic Investment to Build Transdermal Tech Infrastructure with Super-Hydration Beauty Device

VCBeat has learned at the earliest opportunity that,A High-End Tech-Driven Skincare Brand Under YOUNGMAY Biotech“YOUNGMAYYOUNGMAY”Following3In [Month], announced the completion of tens of millions in funding from Meihua Venture Capital and Gaozhang Capital.Pre-Aafter the round of financing, againCompletedStrategic Financing; The Exclusive Strategic Investor in This Round is the Listed Company Ruoyuchen。Meanwhile,YOUNGMAY has established a deep strategic partnership with its new shareholder, Ruoyuchen, in the area of market sales.

It is reported that YOUNGMAY’s at-home Ultra Hydro-Light Beauty Device, when used in combination with its No. 0 Basic Spacetime Hydro-Light Essence, ranked within the top 10 best-selling products in the platform’s beauty device category and claimed the number one spot in the at-home hydro-light device segment just two months after its exclusive launch on the Taobao ecosystem. As a premium-priced domestic beauty device, it maintains strong daily sales volume, with ROI and repurchase rates three times higher than the industry average.

Although the hardware of YOUNGMAY’s ultra-hydration device is priced at twice that of standard hydration devices, its daily sales performance has been exceptionally strong since launch. On the surface, YOUNGMAY entered the hydration device market one year later than its competitors. In reality, unlike hardware, the technological barriers behind YOUNGMAY’s products stem entirely from the proprietary serums used as consumables. YOUNGMAY is one of the few brands in the home-use hydration market with in-house R&D capabilities for hydration serums.

Essentially, a hydro-lifting device is a piece of hardware that enables standardized control over injection force and fluid delivery efficiency. Its function is to replace manual operations and enhance infusion efficiency. For instance, manually administering 2.5 mL of serum takes over 40 minutes, whereas using a specially developed device can shorten the entire infusion process to approximately 5 minutes, saving users significant time in their skincare routines.

The nano-microcrystalline chips included with the product essentially serve as a medium for transdermal drug delivery. Each chip is embedded with hundreds of nanoscale microneedles that temporarily open absorption channels in the stratum corneum without causing pain or requiring a recovery period. Relying on the skin’s natural elasticity, these channels automatically close within 20 minutes. Although this technology was first proposed in the United States over a century ago and has been mature in China for more than a decade, appearing to be a highly effective skincare approach, why have related products only just begun to enter the market?

The answer is: A single device equipped with a nanochip is ineffective for skincare.

The founder of YOUNGMAY Technology stated, “YOUNGMAY has been strategically positioned in this sector for five years. Since the barriers to designing and manufacturing hardware devices are relatively low, we completed the development, iteration, and mass production of this luxury-grade device in approximately 18 months. Over these five years, our core focus has been on addressing the efficacy and safety of transdermal delivery using nanocrystals. We extensively evaluated various technologies in the global transdermal drug delivery field, including physical microneedles, pneumatic transdermal systems, dissolvable microneedles, and various organic and inorganic microneedles, ultimately selecting nanocrystals as the most suitable solution.”

It is understood that nanocrystalline chips possess inorganic properties, ensuring safe use with no pain, no invasiveness, and no recovery period. From a technical perspective, the skin channels opened by nanocrystals are extremely fine; each contact with the skin precisely penetrates the intercellular spaces of the stratum corneum, creating hundreds of nanoscale absorption pathways. However, to achieve effective application in the skincare sector—where demand is absolute and the market is vast—many challenges must still be overcome. Otherwise, it will merely amount to storytelling for users, appearing impressive on the surface but failing to deliver substantive benefits.

In brief, the mesotherapy device category features one advantage and two challenges. The advantage lies in regulatory classification, which deems this technology suitable for home use, resulting in a significantly higher market ceiling compared to invasive, skin-penetrating professional-grade mesotherapy injections. However, the challenges stem from the fact that the molecular structures of many functional active ingredients heavily added to skincare products are enormous relative to nanoscale channels—much like “a large person trying to squeeze through a small window.”

Merely applying nanocrystals and developing a beauty device hardware does not truly bring about significant improvements in skincare efficacy. Since its establishment in 2017, YOUNGMAY has spent most of the past five years quietly tackling this challenge. YOUNGMAY’s essence utilizes its proprietary 7D Super Hydrating Molecular Technology, which breaks down large-molecule active ingredients in the laboratory. These ingredients are then delivered directly to various skin layers through the stratum corneum barrier using nanocrystals. Finally, they self-assemble and reaggregate beneath the skin to exert their effects. This approach achieves efficacy dozens of times higher than topical application and comparable to professional-grade hydrating treatments, thoroughly resolving the issue of poor absorption of active ingredients by ordinary hydrating devices.

The micro-crosslinks formed by YOUNGMAY’s essence via subcutaneous self-assembly possess potent targeted transdermal delivery and sustained-release capabilities, delivering superior skincare efficacy.

Another challenge lies in the vast differences between topical skincare products and infusion-based serums, ranging from manufacturing processes to formulation technologies. Ordinary topical serums have relatively low requirements for production techniques and formulations. In contrast, products designed for intradermal delivery essentially require medical-device-grade manufacturing processes to ensure safety and stability. Directly integrating ordinary skincare products with microcrystalline chips for transdermal delivery can easily trigger severe allergic reactions.

YOUNGMAY’s R&D team hails from the pharmaceutical R&D and synthetic biology sectors. Internally, the team consistently adheres to the philosophy of “applying pharmaceutical and medical device logic to efficacy-based skincare,” rigorously implementing this approach in every ingredient, every claimed benefit, and the development of each serum. This may well be the foundation of confidence and strength that enables YOUNGMAY to stand out amidst competitors with more funding rounds and earlier market entry.

The advantages of Super Shuiguang lie in its painless, non-invasive nature and zero downtime, while achieving better absorption and stronger efficacy than ordinary home-use Shuiguang devices. Its self-assembling sustained-release mechanism further prolongs the effects. As the founder of YOUNGMAY stated, “What we are actually selling is the serum, not the beauty device itself.” The essence of Super Shuiguang is that it is “super” in terms of the serum.

Upon the completion of this round of financing, YOUNGMAY Technology has taken a significant step forward. The company announced the official establishment of the “YOUNGMAY Nano Transdermal Promotion Laboratory” to continue its in-depth research and development in transdermal drug delivery and hair growth promotion technologies. This will become the world’s first skincare R&D platform dedicated exclusively to transdermal technology. YOUNGMAY will collaborate with institutions and enterprises such as the National Center for Nanoscience and Technology, Huazhong University of Science and Technology, Suzhou Nano Industrial Park, and Harbin Institute of Technology to jointly build new infrastructure for transdermal technology.

YOUNGMAY has officially become a hard-tech enterprise integrating a high-end proprietary tech-driven skincare brand with transdermal biotechnology R&D. The company’s current and existing technological achievements in the field of transdermal skincare are at an internationally leading level. Meanwhile, YOUNGMAY Biotech is also developing proprietary ingredients derived from synthetic biology for skincare applications, primarily targeting anti-wrinkle, anti-aging, and regenerative effects, which have demonstrated significant efficacy in human clinical trials. It remains unconfirmed whether these ingredients will be made available for sale to other skincare brands in the market. The related product serums are expected to be officially launched in Q4 of this year.

“YOUNGMAY’s ‘Super Shuiguang’ is a new product category born from the commercialization of scientific and technological achievements. Compared to the three giants in the medical aesthetics industry, we still have a long way to go. YOUNGMAY has chosen to serve end consumers directly through product and technological innovation, striving to pioneer a new category led by Chinese brands on the global stage. This is not only our mission but also reflects the national confidence of our generation of post-90s entrepreneurs. We extend our sincere gratitude to our shareholders for their strong support; it was no small feat for YOUNGMAY to secure consecutive rounds of financing against the tide amidst a cooling consumer market and the challenges posed by the pandemic. We are even more grateful to our consumers for their trust in YOUNGMAY and for their robust support of a new domestic brand with such a high average transaction value. Building a premium brand is a long and cautious journey that tests product strength, brand equity, aesthetic sensibility, innovation capability, service systems, and corporate cash flow. In the future, YOUNGMAY will uphold its corporate values of continuous improvement, increase investment in R&D and talent, ensure healthy cash flow, and develop more high-quality, efficient end-products to meet the high standards of diverse consumers, thereby bringing honor to Chinese brands,” said the founder of YOUNGMAY.